Understanding The Role of Ubiquitin-conjugating Enzyme E2 Q1 (G55585)

Target Name: UBE2Q1

NCBI ID: G55585

UBE2Q1

Understanding The Role of Ubiquitin-conjugating Enzyme E2 Q1

Ubiquitin-conjugating enzyme E2 Q1 (UBE2Q1) is a protein that plays a crucial role in the regulation of protein degradation in the cell. It is a member of the ubiquitin enzyme family and is responsible for the covalent attachment of ubiquitin to target proteins. The Ubiquitin-conjugating enzyme E2 Q1 is widely expressed in various cell types and is involved in various cellular processes, including cell signaling, DNA damage repair, and stress resistance.

UBE2Q1 functions as an enzyme that adds a ubiquitin molecule to the target protein. This process is reversible and allows for the targeted degradation of target proteins. UBE2Q1 is also involved in the regulation of protein stability and can alter the stability of different proteins.

The Ubiquitin-conjugating enzyme E2 Q1 is a potential drug target in the pharmaceutical industry due to its involvement in various cellular processes. It is a good candidate for anti-cancer drugs because it is involved in cell signaling, which is a key factor in cancer development.

UBE2Q1 has also been shown to be involved in DNA damage repair. damaged DNA is a hallmark of cancer and is a major cause of cancer-related death. UBE2Q1 plays a role in repairing damaged DNA by adding a ubiquitin molecule to the damaged DNA. This helps to stabilize the DNA and prevent it from being broken down by other enzymes.

Another potential application of UBE2Q1 as a drug target is its role in stress resistance. Stress can cause proteins to become unstable and can lead to protein degradation. UBE2Q1 helps to prevent this by adding a ubiquitin molecule to target proteins, which can increase their stability and reduce their degradation.

UBE2Q1 is also involved in cell signaling and can alter the stability of different proteins. This can have a significant impact on the function of cells and the development of diseases. For example, UBE2Q1 has been shown to play a role in the regulation of cell signaling, which is critical for the development of cancer.

In conclusion, Ubiquitin-conjugating enzyme E2 Q1 (UBE2Q1) is a protein that is involved in various cellular processes, including cell signaling, DNA damage repair, and stress resistance. It is a potential drug target due to its involvement in these processes and can be used to treat various diseases. Further research is needed to fully understand the role of UBE2Q1 as a drug target and to develop effective treatments.

Protein Name: Ubiquitin Conjugating Enzyme E2 Q1

Functions: Catalyzes the covalent attachment of ubiquitin to other proteins (PubMed:22496338). May be involved in hormonal homeostasis in females. Involved in regulation of B4GALT1 cell surface expression, B4GALT1-mediated cell adhesion to laminin and embryoid body formation (By similarity)

The "UBE2Q1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about UBE2Q1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets